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Introduction: Chronic expanding hematoma is a rare persistent hematoma that can sometimes be misdiagnosed
as a malignant tumor due to its clinical and radiological features.
Case presentation: A 42-year-old Japanese man with a large mass in his leg, suggestive of malignancy, presented
to our hospital. He had been aware of the leg swelling for the last eight years. A magnetic resonance imaging scan
demonstrated a large mass with two components. One was a large, well-defined cystic mass (13×9cm) showing
high intensity on T1- and T2-weighted images, and the other was a solid mass (3.5×2.5cm, adjacent to the large
mass) with high intensity on T1-weighted images. Two-[18F]fluoro-2 deoxy-D glucose positron emission tomography
images revealed increased uptake with a maximum standardized uptake value of 15.8 in the solid mass. As these
findings were considered suggestive of hematoma associated with a malignant lesion, an open biopsy was
performed. A pathological examination demonstrated a hematoma with xanthogranuloma, and no malignant cells
were evident. Therefore, we resected the tumor including both components, and the histological diagnosis was
chronic expanding hematoma. Clinical diagnosis based on 2-[18F]fluoro-2 deoxy-D glucose uptake is sometimes
limited by the fact that 2-[18F]fluoro-2 deoxy-D glucose is taken up by not only malignant tumor cells but also
macrophages and tissues with granulation or inflammation.
Conclusions: Significantly increased standardized uptake value in the peripheral rim of the lesion on 2-[18F]fluoro-2
deoxy-D glucose positron emission tomography imaging, mimicking a soft tissue sarcoma, should be recognized as
a potential diagnostic pitfall in cases of chronic expanding hematoma.
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Figure 1 Magnetic resonance imaging scan. Axial magnetic resonance imaging (T2, Gd-enhanced) views show a well-defined cystic mass
(red arrow) with debris in the right medial calf (A), and a Gd-enhanced solid lesion in the medial gastrocnemius (blue arrow) (B).
Figure 2 Two-[18F]fluoro-2 deoxy-D glucose positron emission
tomography image. Axial fused 2-[18F]fluoro-2 deoxy-D glucose
positron emission tomography image shows abnormal 2-[18F]fluoro-2
deoxy-D uptake (maximum standardized uptake value: 15.8) in the solid
lesion (blue arrow) adjacent to the cystic lesion (red arrow).
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Chronic expanding hematoma (CEH) is a rare lesion
that was first defined by Reid et al. in 1980 [1]. CEH is
characterized by its persistence and increasing size over
a period of more than a month after the initial hemor-
rhage, whereas most hematomas in skeletal muscle may
arise with or without any identifiable trauma and grad-
ually expand over days to weeks, followed by a decrease
in size or disappearance within a few months. Therefore,
CEH can be misdiagnosed as a malignant soft tissue
sarcoma because of its clinical characteristics such as a
large size and slowly progressive enlargement [1,2]. Two-
[18F]fluoro-2 deoxy-D glucose positron emission tomog-
raphy (FDG-PET) is an evolving diagnostic modality used
for tumor detection, staging, therapeutic monitoring and
follow-up evaluations for the treatment and management
of various malignant tumors [3,4].
Here we present a case of CEH in the lower extremity.
The lesion exhibited significantly increased FDG uptake
on FDG-PET, mimicking the characteristics of a soft tis-
sue sarcoma accompanied by hematoma.
Case presentation
A 42-year-old Japanese man was referred to our hospital
because of pain in his right leg. He had first become
aware of pain in his leg during a rugby game eight years
previously. Although the pain had subsequently im-
proved, his leg had remained swollen for several years,
without having suffered any obvious trauma or received
any anticoagulant therapy. Before referral to our hos-
pital, he had developed renewed pain in his leg for one
month. Upon physical examination, a large hard mass
was palpable in his right leg. A magnetic resonance im-
aging (MRI) scan showed a 13×9-cm cystic mass with
high signal intensity on T1- and T2-weighted images
between the soleus and lateral gastrocnemius, and a3.5×2.5-cm solid lesion with high signal intensity on T1-
weighted images in the medial gastrocnemius. This solid
lesion adjacent to the cystic mass was enhanced on Gd-
enhanced T1-weighted images (Figure 1A, B). FDG-PET
images revealed increased uptake with a maximum stan-
dardized uptake value (SUV) of 15.8 in the solid lesion
(Figure 2). As these clinical findings and diagnostic im-
ages were considered suggestive of hematoma associated
with a malignant lesion, an open biopsy of both compo-
nents was performed. A pathological examination revealed
that the lesions consisted of a mixture of hematoma and
Figure 3 Histopathological features. (A) The biopsy specimen shows a mixture of hematoma and xanthogranuloma, with no malignant cells.
(B-D) A hematoma accompanied by accumulation of fibrin, cholesterin crystals, and histiocytes.
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Therefore, complete resection of the masses was performed
based on a diagnosis of CEH after obtaining informed
consent. During the operation, no active hemorrhaging or
a source of bleeding was identified. The resected specimen
was a dark brown, partially organized hematoma sur-
rounded by fibrous tissues. A postoperative pathological
examination yielded a diagnosis of hematoma accompan-
ied by accumulation of fibrin, cholesterin crystals, and his-
tiocytes in the cystic region (Figure 3B-D). As of eight
months after surgery, our patient is in good health with no
sign of recurrence.
Discussion
Reid et al. first used the term ‘chronic expanding hema-
toma’ for hematomas that persisted and increased in size
for more than a month after the initial hemorrhage event
[1]. Such lesions often simulated neoplastic growth. On
the other hand, it has been reported previously that someTable 1 Fluorodeoxyglucose positron emission tomography i
Authors Sex/Age (years) Location
Hamada et al. [10] M/65 Ilium
Kwon et al. [11] F/67 Hemithorax
Takahama et al. [12] M/77 Chest wall
Tokue et al. [13] M/77 Intrapericardia
Present case M/42 Leg
FDG, 2-[18F]fluoro-2 deoxy-D glucose; PET, positron emission tomography; SUVmax,soft tissue sarcomas, including synovial sarcoma, epitheli-
oid sarcoma, extraskeletal Ewing sarcoma, and malignant
fibrous histiocytoma, sometimes exhibit the radiological
features of a hematoma. Such clinical and radiological fea-
tures often make the accurate diagnosis of pure hematoma
difficult. The mechanisms that determine the formation of
CEH are not well understood. Labadie and Glover theo-
rized that breakdown of leukocytes, hemoglobin, plate-
lets, and fibrin results in an inflammatory process that
effectively damages the capillaries of the capsule, increas-
ing the permeability of the vascular wall and causing
bleeding from dilated microvessels underneath the fi-
brous capsule [5].
Various kinds of imaging modalities have been utilized
for diagnosis of CEH. FDG-PET imaging is increasingly
being used in clinical oncology because it enables func-
tional imaging of various tumors. Generally, high-grade
sarcomas and aggressive benign lesions such as desmoid-
type fibromatosis and giant cell tumor of tendon sheathmaging characteristics of chronic expanding hematoma
Size (cm) Treatment SUVmax
8 Resection 3.1
ND Resection 3.7
4.5 Open puncture 5.5
l 9 Resection 3.5
13 Resection 15.8
maximum standardized uptake value; ND, no data.
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However, it is also known that tumor diagnosis based on
FDG-PET imaging is limited by the fact that FDG is taken
up by not only tumor cells but also macrophages, granula-
tion and inflammation tissue [7]. High uptake of FDG has
been observed in many kinds of inflammatory lesions, in-
cluding chronic osteomyelitis, tuberculosis, and rheuma-
toid arthritis. A previous study has also indicated that
macrophages and immature granulation tissue containing
fibroblasts contribute to the increase uptake of FDG in tu-
mors [8]. Knight et al. has also reported that active granu-
lomatous processes such as tuberculosis accumulate FDG
and cause false positivity during PET evaluation of malig-
nancy [9]. In the present case, the solid lesion containing
xanthogranulation showed increased FDG uptake. To
date, the FDG-PET imaging features of CEH have not
been clearly established. A few past reports have indicated
that the peripheral portion of a CEH arising from the
thorax or pelvic cavity tends to take up FDG within a
SUVmax range of 3.1 to 5.5 (Table 1). This pattern is also
evident in soft tissue sarcomas with a tendency for central
necrosis. To the best of our knowledge, such a significantly
high FDG uptake (SUVmax was 15.9) in a CEH arising from
the extremity has not been reported previously. In this
case, despite increased FDG uptake in the solid lesion at
the peripheral rim, the final histological diagnosis was CEH
with no malignancy. Therefore, a significantly increased
SUV in the peripheral rim of CEH in FDG-PET images
should be recognized as a potential diagnostic pitfall mim-
icking a soft tissue sarcoma with hematoma formation.
Although the treatment of CEH is still a matter of de-
bate, most authors have recommended surgical resec-
tion. Aspiration or drainage of the material may not
remove the clot contents fully, and undoubtedly will not
remove the fibrous wall that might retain fluid. Add-
itionally, aspiration of the fluid or incomplete excision
could lead either to an unconfirmed diagnosis or to re-
currence [14]. Hanagiri et al. reported that the surgical
procedure should be complete resection, because incom-
plete resection might result in massive bleeding from a
hypervascular subcapsular lesion [15]. Therefore, it seems
that complete surgical resection, including the pseudocap-
sule, is the best treatment option for CEH.
Conclusions
In summary, we have presented a case of CEH showing sig-
nificantly increased FDG accumulation, which could have
had the potential for misdiagnosis as a soft tissue sarcoma.
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